TE_3665
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR78 |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | ENSG00000291325 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 0.05 |
| Counts of samples | TCGA_tumor:3; TCGA_normal:14; GTEx:71 |
| TSS | chr2(+):4283995 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_3665.1 | ENSG00000291325 | Annoated | Non-coding | Non-coding | chr2(+):4283996,4284270,4438966,4439087,4450907,4451031,4510045,4510159,4627365,4627453,4629158,4629178 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
